Because we also observed a notable increase in the average expression of the CD262 per cell in MM cell lines after treatment with BZ, we explored the possibility of combining the treatment of BZ + FINM with the expression of TRAIL, which can induce the apoptosis in TRAIL-R (CD262) expressing cells, mostly tumor cells [52] including MM cells [53]. The gene discussed is TNFRSF10B; the disease is neoplasm.